A double-blind placebo-controlled cross-over clinical trial of DONepezil In Posterior cortical atrophy due to underlying Alzheimer's Disease: DONIPAD study

A double-blind placebo-controlled cross-over clinical trial of DONepezil In Posterior cortical atrophy due to underlying Alzheimer's Disease: DONIPAD study

Abstract Background The study investigated whether donepezil exerts symptomatic benefit in patients with posterior cortical atrophy (PCA), an atypical variant of Alzheimer’s disease. Methods A single-centre, double-blind, placebo-controlled, cross-over clinical trial was performed to assess the effi...

Full description

Bibliographic Details
Main Authors: Basil H. Ridha, Sebastian Crutch, Dawn Cutler, Christopher Frost, William Knight, Suzie Barker, Norah Epie, Elizabeth K. Warrington, Riitta Kukkastenvehmas, Jane Douglas, Martin N. Rossor
Format: Article
Language:English
Published: BMC 2018-05-01
Series:Alzheimer’s Research & Therapy
Subjects:
Posterior cortical atrophy
Alzheimer’s disease
Donepezil
Clinical trial
Online Access:http://link.springer.com/article/10.1186/s13195-018-0363-1

Internet

http://link.springer.com/article/10.1186/s13195-018-0363-1

Similar Items